PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Expedeon Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Novexin's Sales Boosted by InstantBlue Gel Stain - Novexin reports rapidly increasing sales of its novel InstantBlue single step protein gel stain
Novexin's Sales Boosted by InstantBlue Gel Stain

 

NewswireToday - /newswire/ - Cambridge, Cambridgeshire, United Kingdom, 2007/02/19 - Novexin reports rapidly increasing sales of its novel InstantBlue single step protein gel stain.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Novexin Ltd ('Novexin') the innovative company specialising in improved technologies and products for protein science reports rapidly increasing sales of their novel InstantBlue product.

InstantBlue, based on the Coomassie blue stain, provides two key advantages over other available products for straining protein bands in SDS-PAGE gels:

• It provides a result in 15 minutes compared with 1 hour typical for competing products;
• It requires a one step procedure and eliminates the multi-step requirements of other products.

Since its launch in July 2006 sales of InstantBlue have grown rapidly bringing in new customers worldwide. Novexin (novexin.com) is already selling to over 200 different companies, including major biotech and pharmaceutical companies with the product showing its popularity though reorders and recommendations.

Dr Dan Jones Director of Novexin states “Through InstantBlue we have applied our technology to a procedure used routinely in most labs concerned with proteins to give our customers more rapid results and increased productivity. Our rapidly expanding sales of this product reflect the positive impact this has had in industry and academia. In both areas we have had an excellent uptake rate both in the UK and abroad”

Clare Stevenson from the John Innes Centre commented “Does exactly what it says on the container - A small quantity is added directly to the gel and the protein bands are visible in minutes; no need to wash or destain the gel; quicker and easier than other stains on the market and just as sensitive”

While Dr Mark Abbot from, AstraZeneca commented “Instant Blue means I can plan my next experiment within 5 minutes rather than having to wait for 2-3 hours to stain and destain a gel.”

With this product Novexin has continued with their aim to provide effective solutions to common problems in protein science, concentrating on simplicity in design and effectiveness in applicability.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Expedeon Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Novexin's Sales Boosted by InstantBlue Gel Stain

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Luke Scicluna - Novexin.com 
+44(0)12 2349 6500 novexin[.]novexin.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Expedeon Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Expedeon Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  MagLar, Inc.

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)